New Special Report on Pharma in Cyprus
With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare and life sciences investment destination. However, with…
Standing at the crossroads of three continents, Cyprus embodies the beauty and diversity of Mediterranean culture. Being tucked beneath Turkey and hugging the western shores of the Middle East gives a distinct eastern feel to the island nation. Yet the…
With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare and life sciences investment destination. However, with…
In a move to capitalize on a global market projected to exceed USD 60 billion by 2024, Cyprus has joined a growing number of European nations in legally permitting the…
Cyprus is capitalizing on its well-established tourism infrastructure to stake a claim for itself as one of Europe’s premier medical tourism destinations. “I believe Cyprus can become a really important…
Healthcare and life science industry advisory services head at KPMG Cyprus, Iacovos Ghalanos, discusses the challenge of implementing the National Health Insurance Scheme, pricing pressures and how their innovative services help companies manage this crucial trend. Ghalanos also touches on the need for greater collaboration between the public and private sectors. How important do you feel the implementation of…
Polis Peratikos of the Cyprus Health Services Promotion Board leads the operation promoting the healthcare tourism capabilities of Cyprus across the world, notably in the UK and Russia. In this…
Varnavas Varnava, the founder and director of Biotronics, highlights the importance of diversification when operating in a small market, as well as discloses his future plans for the company and…
See our Cookie Privacy Policy Here
